Biological and clinical significance of quorum sensing alkylquinolones: current analytical and bioanalytical methods for their quantification

被引:8
作者
Montagut, Enrique J. [1 ,2 ]
Marco, M. Pilar [1 ,2 ]
机构
[1] Spanish Council Sci Res CSIC, Nanbiotechnol Diagnost Nb4D, Dept Surfactants & Nanobiotechnol, Inst Adv Chem Catalonia IQAC, Jordi Girona 18-26, Barcelona 08034, Spain
[2] CIBER Bioingn Biomat & Nanomed CIBER BBN, Jordi Girona 18-26, Barcelona 08034, Spain
关键词
Alkylquinolones; Quorum sensing; Pseudomonas aeruginosa; Quantification; Detection; Diagnostic; PSEUDOMONAS-QUINOLONE SIGNAL; CYSTIC-FIBROSIS; ANALYSIS REVEALS; RAPID DETECTION; P; AERUGINOSA; LC-MS/MS; MOLECULES; PQS; PYOCYANIN; SYSTEM;
D O I
10.1007/s00216-021-03356-x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Quorum sensing (QS) is a sophisticated bacterial communication system which plays a key role in the virulence and biofilm formation of many pathogens. The Pseudomonas aeruginosa QS network consists of four sets of connected systems (las, rlh, pqs and iqs) hierarchically organized. The pqs system involves characteristic autoinducers (AI), most of them sharing an alkylquinolone (AQ) structure, and is able to carry out several relevant biological functions besides its main signalling activity. Their role in bacterial physiology and pathogenicity has been widely studied. Indeed, the presence of these metabolites in several body fluids and infected tissues has pointed to their potential value as biomarkers of infection. In this review, we summarize the most recent findings about the biological implications and the clinical significance of the main P. aeruginosa AQs. These findings have encouraged the development of analytical and bioanalytical techniques addressed to assess the role of these metabolites in bacterial growth and survival, during pathogenesis or as biomarkers of infections. The availability of highly sensitive reliable analytical methods suitable for clinical analysis would allow getting knowledge about pathogenesis and disease prognosis or progression, supporting clinicians on the decision-making process for the management of these infections and guiding them on the application of more effective and appropriate treatments. The benefits from the implementation of the point-of-care (PoC)-type testing in infectious disease diagnostics, which are seen to improve patient outcomes by promoting earlier therapeutic interventions, are also discussed.
引用
收藏
页码:4599 / 4618
页数:20
相关论文
共 133 条
  • [1] Pseudomonas Quinolone Signal Induces Oxidative Stress and Inhibits Heme Oxygenase-1 Expression in Lung Epithelial Cells
    Abdalla, Maher Y.
    Hoke, Traci
    Seravalli, Javier
    Switzer, Barbara L.
    Bavitz, Melissa
    Fliege, Jill D.
    Murphy, Peter J.
    Britigan, Bradley E.
    [J]. INFECTION AND IMMUNITY, 2017, 85 (09)
  • [2] A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms
    Allesen-Holm, M
    Barken, KB
    Yang, L
    Klausen, M
    Webb, JS
    Kjelleberg, S
    Molin, S
    Givskov, M
    Tolker-Nielsen, T
    [J]. MOLECULAR MICROBIOLOGY, 2006, 59 (04) : 1114 - 1128
  • [3] Baig N, 2016, P SPIE INT SOC OPT E, P9930
  • [4] Augmentation of virulence related traits of pqs mutants by Pseudomonas quinolone signal through membrane vesicles
    Bala, Anju
    Kumar, Lokender
    Chhibber, Sanjay
    Harjai, Kusum
    [J]. JOURNAL OF BASIC MICROBIOLOGY, 2015, 55 (05) : 566 - 578
  • [5] Metabolic Phenotyping and Strain Characterisation of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Using Rapid Evaporative Ionisation Mass Spectrometry
    Bardin, Emmanuelle E.
    Cameron, Simon J. S.
    Perdones-Montero, Alvaro
    Hardiman, Kate
    Bolt, Frances
    Alton, Eric W. F. W.
    Bush, Andrew
    Davies, Jane C.
    Takats, Zoltan
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [6] Barr HL, 2017, J CYST FIBROS, V16, P230, DOI [10.1016/j.jcf.2016.10.005, 10.1016/j.jcf.2017.09.008]
  • [7] Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
    Barr, Helen L.
    Halliday, Nigel
    Camara, Miguel
    Barrett, David A.
    Williams, Paul
    Forrester, Douglas L.
    Simms, Rebecca
    Smyth, Alan R.
    Honeybourne, David
    Whitehouse, Joanna L.
    Nash, Edward F.
    Dewar, Jane
    Clayton, Andrew
    Knox, Alan J.
    Fogarty, Andrew W.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 1046 - 1054
  • [8] Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment
    Blanchard, Ana C.
    Rooney, Ashley M.
    Yau, Yvonne
    Zhang, Yu
    Stapleton, Patrick J.
    Horton, Eric
    Klingel, Michelle
    Stanojevic, Sanja
    Ratjen, Felix
    Coburn, Bryan
    Waters, Valerie
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (06) : 723 - 728
  • [9] Development and bioanalytical method validation of an LC-MS/MS assay for simultaneous quantitation of 2-alkyl-4(1H)-quinolones for application in bacterial cell culture and lung tissue
    Brewer, Luke K.
    Jones, Jace W.
    Blackwood, Catherine B.
    Barbier, Mariette
    Oglesby-Sherrouse, Amanda
    Kane, Maureen A.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2020, 412 (07) : 1521 - 1534
  • [10] Advanced Methods for MALDI-MS Imaging of the Chemical Communication in Microbial Communities
    Brockmann, Eike Ulrich
    Steil, Daniel
    Bauwens, Andreas
    Soltwisch, Jens
    Dreisewerd, Klaus
    [J]. ANALYTICAL CHEMISTRY, 2019, 91 (23) : 15081 - 15089